CIK 0001645460
- Non-accelerated filer
- Smaller reporting company
Cue Biopharma, Inc.
Sign in to watch- Ticker
- CUE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473324577
- Phone
- +1 617-949-2680
- Business address
- 100 CHESTNUT STREET, SUITE 300, SOMERVILLE, MA, 02143
- Former names
- Imagen Biopharma, Inc.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 5 Insider Annual Insider Trading Report
- 4 Open-market buy Chief Medical Officer bought 2,720 shares at $15.07 ($40,980)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 6,548 shares at $12.64 ($82,776)
- 4 Shares withheld for taxes President and CSO gave up 9,800 shares (to pay taxes)
- 4 Open-market buy Director bought 10,000 shares at an average $15.15 ($151,500)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes CFO gave up 1,900 shares (to pay taxes)
- 4/A Open-market sale SVP, General Counsel and Sec sold 13,374 shares at $20.00 ($267,480)
- 4 Open-market sale SVP, General Counsel and Sec sold 13,274 shares at $20.00 ($265,480)
Page 8 of 13 · 259 filings